Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

NCT05819827 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05819827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05819827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Terminated
Start date
April 19, 2023
Completion date
May 21, 2024
Enrollment
13 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, bladder carcinoma, genitourinary system carcinoma, malignant testicular neoplasm, melanoma, prostate cancer, prostate carcinoma, sarcoma, testicular cancer